Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

The president's halt on "wasteful" penny production could cause the value of the rarest one-cent coins to surge.

The most valuable of those coins — a 1976 ... sold for $8,400 in 2023. 1976-D Clad Bicentennial Quarter Regular Strike: sold for $6,463 in 2017. 1976-S Clad Proof Bicentennial Quarter: sold ...

President Trump said he wants the U.S. Treasury to stop making pennies. Can he do a penny drop? Does it need Congressional ...

Hosted a virtual key opinion leader (KOL) event on November 20, 2024 featuring Abhishek Ray, MD (University Hospitals) and Andrew Webb, PharmD, BCCCP (Massachusetts General Hospital), who discussed ...

Jerry Petros, the owner of Alliance Coins and Jewelry in Alliance, said the U.S. should have dumped pennies years ago.

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

Operator: Good day, and welcome to the Aethlon Medical Third Quarter Fiscal 2025 Earnings and Corporate Update Call. All ...

The U.S. Mint is now selling the 2025 Native American $1 coin, which features Hawaiian scholar and composer Mary Kawena Pukui.

Phasing out the penny could result in needing to make more nickels, and the U.S. Treasury Department loses far more money on ...